Effect of active vitamin D on expression of co-stimulatory molecules and HLA-DR in renal transplant recipients

Experimental and Clinical Transplantation

Volumn 7, Issue 2, 2009, Pages 99-103

  Ahmadpoor, Pedram ^a   Ilkhanizadeh, Behrooz ^b   Ghasemmahdi, Laila ^b   Makhdoomi, Khadije ^b   Ghafari, Ali ^b  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b URMIA UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

1, 25 dihydroxyvitamin D3; 1,25(OH)2D3; Allograft survival; Immunomodulation; T cells

Indexed keywords

CALCITRIOL; CD28 ANTIGEN; CD40 ANTIGEN; CD86 ANTIGEN; CYCLOSPORIN; CYTOKINE; HLA DR ANTIGEN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; T LYMPHOCYTE RECEPTOR; VITAMIN;

ADULT; ANTIGEN EXPRESSION; ANTIGEN SPECIFICITY; ARTICLE; CELL DIFFERENTIATION; CELL MATURATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; FEMALE; FLOW CYTOMETRY; GRAFT RECIPIENT; GRAFT SURVIVAL; HUMAN; HYPERCALCEMIA; IMMUNOREGULATION; INHIBITION KINETICS; KIDNEY ALLOGRAFT; KIDNEY GRAFT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LEUKOCYTE; LYMPHOCYTE PROLIFERATION; MALE; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; TREATMENT DURATION; TREATMENT OUTCOME; CELL PROLIFERATION; CLINICAL TRIAL; DRUG EFFECT; GRAFT REJECTION; IMMUNE SYSTEM; KIDNEY; METABOLISM; MIDDLE AGED; ORAL DRUG ADMINISTRATION; PATHOLOGY; PHYSIOLOGY; PROSPECTIVE STUDY; T LYMPHOCYTE;

ADMINISTRATION, ORAL; ADULT; ANTIGENS, CD28; ANTIGENS, CD40; ANTIGENS, CD86; CALCITRIOL; CELL PROLIFERATION; FEMALE; GRAFT REJECTION; HLA-DR ANTIGENS; HUMANS; IMMUNE SYSTEM; KIDNEY; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; T-LYMPHOCYTES; VITAMINS;

EID: 70350501506     PISSN: 13040855     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. van Duivenvoorde LM, van Mierlo GJ, Boonman ZF, Toes RE. Dendritic cells: vehicles for tolerance induction and prevention of autoimmune diseases. Immunobiology. 2006; 211(6-8):627-632. (Pubitemid 44241641)
2. Alegre ML. Costimulatory molecules as targets for the induction of transplantation tolerance. Nephrol Dial Transplant. 1999;14(2):322-332. (Pubitemid 29062786)
3. Vincenti F, Larsen C, Durrbach A, et al. Co-stimulation blockade with belatacept in renal transplantation. N Engl J Med. 2005;353(8):770-781. (Pubitemid 41215486)
4. Sharpe AH, Abbas AK. T-cell costimulation--biology, therapeutic potential, and challenges. N Engl J Med. 2006;355(10):973-975.
5. Sayegh MH, Turka LA. The role of T-cell costimulatory activation pathways in transplant rejection. N Engl J Med.1998;338(25):1813-1821. (Pubitemid 28277962)
6. Cantorna MT, Zhu Y, Froicu M, Wittke A. Vitamin D status, 1,25-dihydroxyvitamin D3, and the immune system. Am J Clin Nutr. 2004;80(6 Suppl):1717S-1720S.
7. Nagpal S, Na S, Rathnachalam R. Noncalcemic actions of vitamin D receptor ligands. Endocr Rev. 2005;26(5):662-687. (Pubitemid 41127276)
8. Rigby WF, Stacy T, Fanger MW. Inhibition of T lymphocyte mitogenesis by 1,25-dihydroxyvitamin D3 (calcitriol). J Clin Invest. 1984;74(4):1451-1455. (Pubitemid 15200239)
9. Piemonti L, Monti P, Sironi M, et al. Vitamin D3 affects differentiation, maturation, and function of human monocyte-derived dendritic cells. J Immunol. 2000;164(9):4443-4451. (Pubitemid 30238038)
10. Adorini L, Penna G, Giarratana N, et al. Dendritic cells as key targets for immunomodulation by Vitamin D receptor ligands. J Steroid Biochem Mol Biol. 2004:89-90(1-5):437-441. (Pubitemid 38844326)
11. Clavreul A, D'hellencourt CL, Montero-Menei C, Potron G, Couez D. Vitamin D differentially regulates B7.1 and B7.2 expression on human peripheral blood monocytes. Immunology. 1998:95(2):272-277.
12. Griffin MD, Lutz WH, Phan VA, Bachman LA, McKean DJ, Kumar R. Potent inhibition of dendritic cell differentiation and maturation by vitamin D analogs. Biochem Biophys Res Commun. 2000:270(3):701-708. (Pubitemid 30444768)
13. Adorini L, Penna G, Giarratana N, Uskokovic M. Tolerogenic dendritic cells induced by vitamin D receptor ligands enhance regulatory T cells inhibiting allograft rejection and autoimmune diseases. J Cell Biochem. 2003;88(2):227-233. (Pubitemid 36119891)
14. Mathieu C, Adorini L. The coming of age of 1,25-dihydroxyvitamin D(3) analogs as immunomodulatory agents. Trends Mol Med. 2002;8(4):174-179.
15. Thornton AM, Shevach EM. CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J Exp Med. 1998:188(2):287-296.
16. Sezer S, Uyar M, Arat Z, Ozdemir FN, Haberal M. Potential effects of 1,25-dihydroxyvitamin D3 in renal transplant recipients. Transplant Proc. 2005;37(7):3109-3111. (Pubitemid 41435635)
17. Redaelli CA, Wagner M, Günter-Duwe D, et al. 1alpha,25- dihydroxyvitamin D3 shows strong and additive immunomodulatory effects with cyclosporine A in rat renal allotransplants. Kidney Int. 2002;61(1):288-296. (Pubitemid 34075156)
18. Redaelli CA, Wagner M, Tien YH, et al. 1alpha,25-Dihydroxycholecalciferol reduces rejection and improves survival in rat liver allografts. Hepatology. 2001;34(5):926-934. (Pubitemid 33032027)
19. Amuchastegui S, Daniel KC, Adorini L. Inhibition of acute and chronic allograft rejection in mouse models by BXL-628, a nonhypercalcemic vitamin D receptor agonist. Transplantation. 2005;80(1):81-87. (Pubitemid 40980899)
20. Hullett DA, Cantorna MT, Redaelli C, et al. Prolongation of allograft survival by 1,25-dihydroxyvitamin D3. Transplantation. 1998;66(7):824-828.
21. Zhang AB, Zheng SS, Jia CK, Wang Y. Effect of 1,25-dihydroxyvitamin D3 on preventing allograft from acute rejection following rat orthotopic liver transplantation. World J Gastroenterol. 2003;9(5):1067-1071. (Pubitemid 36681680)
22. Tanaci N, Karakose H, Guvener H, Tutuncu NB, Colak T, Haberal M. Influence of 1,25-dihydroxyvitamin D3 as an immunomodulator in renal transplant recipients: a retrospective cohort study. Transplant Proc. 2003;35(8):2885-2887. (Pubitemid 38102080)
23. O'Herrin JK, Hullett DA, Heisey DM, Sollinger HW, Becker BN. A retrospective evaluation of 1,25-dihdroxyvitamin D(3) and its potential effects on renal allograft function. Am J Nephrol. 2002;22(5-6):515-520.
24. Tokuda N, Mizuki N, Kasahara M, Levy RB. 1,25-dihydroxyvitamin D3 down-regulation of HLA-DR on human peripheral blood monocytes. Immunology. 1992;75(2):349-354.
25. Vallejo AN, Bryl E, Klarskov K, Naylor S, Weyand CM, Goronzy JJ. Molecular basis for the loss of CD28 expression in senescent T cells. J Biol Chem. 2002;277(49):46940-46949. (Pubitemid 36159198)
26. Weyand CM, Brandes JC, Schmidt D, Fulbright JW, Goronzy JJ. Functional properties of CD4+ CD28- T cells in the aging immune system. Mech Ageing Dev. 1998;102(2-3):131-147.
27. Cella M, Scheidegger D, Palmer-Lehmann K, Lane P, Lanzavecchia A, Alber G. Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. J Exp Med. 1996;184(2):747-752. (Pubitemid 26324129)
28. O'Kelly J, Uskokovic M, Lemp N, Vadgama J, Koeffler HP. Novel Gemini-vitamin D3 analog inhibits tumor cell growth and modulates the Akt/mTOR signaling pathway. J Steroid Biochem Mol Biol. 2006;100(4-5):107-116. (Pubitemid 44175834)
29. van Etten E, Gysemans C, Branisteanu DD, et al. Novel insights in the immune function of the vitamin D system: synergism with interferon-beta. J Steroid Biochem Mol Biol. 2007;103(3-5):546-551. (Pubitemid 46401359)
30. Becker BN, Hullet DA, O'Herrin JK, Malin G, Sollinger HW, DeLuca H. Vitamin D as immunomodulatory therapy for kidney transplantation. Transplantation. 2002;74(8):1204-1206. (Pubitemid 35216124)